首页> 美国卫生研究院文献>Journal of Cardiovascular Development and Disease >Use of Sutureless and Rapid Deployment Prostheses in Challenging Reoperations
【2h】

Use of Sutureless and Rapid Deployment Prostheses in Challenging Reoperations

机译:在挑战性的重新进展中使用不知疲倦和快速部署假肢

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Sutureless and rapid-deployment bioprostheses have been introduced as alternatives to traditional prosthetic valves to reduce cardiopulmonary and aortic cross-clamp times during aortic valve replacement. These devices have also been employed in extremely demanding surgical settings, as underlined in the present review. Searches on the PubMed and Medline databases aimed to identify, from the English-language literature, the reported cases where both sutureless and rapid-deployment prostheses were employed in challenging surgical situations, usually complex reoperations sometimes even performed as bailout procedures. We have identified 25 patients for whom a sutureless or rapid-deployment prosthesis was used in complex redo procedures: 17 patients with a failing stentless bioprosthesis, 6 patients with a failing homograft, and 2 patients with the failure of a valve-sparing procedure. All patients survived reoperation and were reported to be alive 3 months to 4 years postoperatively. Sutureless and rapid-deployment bioprostheses have proved effective in replacing degenerated stentless bioprostheses and homografts in challenging redo procedures. In these settings, they should be considered as a valid alternative not only to traditional prostheses but also in selected cases to transcatheter valve-in-valve solutions.
机译:已经引入了缺陷和快速部署生物制基因作为传统假肢瓣膜的替代品,以减少主动脉瓣膜置换术期间的心肺和主动脉的交叉夹。这些装置也以极其要求的手术设置使用,如目前的审查所强调。在PubMed和Medline数据库中搜索旨在从英语文献中识别报告的案件,其中既定的外科手术情况都采用了不审理和快速部署假体,通常甚至作为救助程序进行复杂的重新进展。我们已经确定了25名患者,其中用于复杂的重做手术中的缺点或快速部署假体:17例无限无止药生物制剂的患者,6名患者失败的同种质,2例患者失败的阀门备件过程。所有患者均存活重新进食,据报道,术后3个月至4年。在挑战的重做程序中,已证明有效地替代退化的无级生物制基团和同质移植物的无效和快速部署生物制基因。在这些设置中,它们不仅应视为有效的替代方案,不仅是传统的假体,而且在选定的情况下被视为有效的替代方案,也可在选定的情况下到经电截管阀门内解决方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号